budfoxfun Tuesday, 04/20/21 07:01:46 AM Re: None Post # of 14408 $GWHP news alert: April 20, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Global WholeHealth Partners (OTC:GWHP) now has the means to identify and test for Dementia using a Micro-Well Reader or Lateral Flow Test to measure the certain brain enzymes during the data collection process used in a positive diagnosis. This was disclosed in an 8K filed March 21, 2021 which can be found by clicking here. "This could simply be described as nothing short of a Medical Breakthrough in Dementia Diagnostic Testing.” -- said Charles Strongo, CEO of Global WholeHealth Partners, Corp (OTC:GWHP). “We believe this announcement couldn’t come at a better time for us as we are partnering with Nunzia Pharmaceutical and their products for Neurological disorders,” said Mr. Strongo. “Nunzia Pharmaceutical with nutraceutical for anxiety and stress based on their patented formula and their pharmaceutical drug they are planning on bringing through the FDA, which specifically works on the Hippocampus part of the brain, dealing with stress, memory, and fine motor skills are a perfect fit for Global’s diagnostic tests,” says Mr. Strongo.